These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 16107832)

  • 1. Unravelling hepatitis C virus replication from genome to function.
    Lindenbach BD; Rice CM
    Nature; 2005 Aug; 436(7053):933-8. PubMed ID: 16107832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into structure and replication of the hepatitis C virus and clinical implications.
    Poenisch M; Bartenschlager R
    Semin Liver Dis; 2010 Nov; 30(4):333-47. PubMed ID: 20960374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
    Gottwein JM; Bukh J
    Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro replication models for the hepatitis C virus.
    Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
    J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into hepatitis C virus replication and persistence.
    Bartenschlager R; Frese M; Pietschmann T
    Adv Virus Res; 2004; 63():71-180. PubMed ID: 15530561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of hepatitis C virus.
    Moradpour D; Penin F; Rice CM
    Nat Rev Microbiol; 2007 Jun; 5(6):453-63. PubMed ID: 17487147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host factors involved in the replication of hepatitis C virus.
    Moriishi K; Matsuura Y
    Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity.
    Sekine-Osajima Y; Sakamoto N; Mishima K; Nakagawa M; Itsui Y; Tasaka M; Nishimura-Sakurai Y; Chen CH; Kanai T; Tsuchiya K; Wakita T; Enomoto N; Watanabe M
    Virology; 2008 Feb; 371(1):71-85. PubMed ID: 17949770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subgenomic replicon model of hepatitis C virus and it's application].
    Jia YT; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):158-60. PubMed ID: 15727718
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C virus replication cycle.
    Bartenschlager R; Cosset FL; Lohmann V
    J Hepatol; 2010 Sep; 53(3):583-5. PubMed ID: 20579761
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C viral life cycle.
    Suzuki T; Ishii K; Aizaki H; Wakita T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1200-12. PubMed ID: 17825945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.
    Abe K; Ikeda M; Dansako H; Naka K; Kato N
    Virus Res; 2007 Apr; 125(1):88-97. PubMed ID: 17239465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture.
    Bartenschlager R
    Curr Opin Microbiol; 2006 Aug; 9(4):416-22. PubMed ID: 16814596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus: virology and experimental systems.
    Liu C
    Clin Liver Dis; 2006 Nov; 10(4):773-91. PubMed ID: 17164117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatitis C virus replicon system: from basic research to clinical application.
    Bartenschlager R
    J Hepatol; 2005 Aug; 43(2):210-6. PubMed ID: 15964655
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b.
    Murakami K; Ishii K; Ishihara Y; Yoshizaki S; Tanaka K; Gotoh Y; Aizaki H; Kohara M; Yoshioka H; Mori Y; Manabe N; Shoji I; Sata T; Bartenschlager R; Matsuura Y; Miyamura T; Suzuki T
    Virology; 2006 Aug; 351(2):381-92. PubMed ID: 16678876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential applications of siRNA in hepatitis C virus therapy.
    Smolic R; Volarevic M; Wu CH; Wu GY
    Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hepatitis C virus life cycle as a target for new antiviral therapies.
    Pawlotsky JM; Chevaliez S; McHutchison JG
    Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.